QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

PVLA

QT75Palvella Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
113.10
+0.47+0.42%
OverviewShort InterestFilings
PVLAQT75Palvella Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
113.10+0.42%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-21.79
Insider Own13.09%
Shs Outstand14.34M
Perf Week6.32%
Market Cap1.33BForward P/E-EPS next Y-6.43Insider Trans0.21%Shs Float-Perf Month3.57%
Enterprise Value1.13BPEG-EPS next Q-1.16Inst Own-Short Float-Perf Quarter-0.71%
Income-44530541.00P/S0.00EPS this Y74.49%Inst Trans-Short Ratio-Perf Half Y16.83%
Sales-P/B6.34EPS next Y-15.73%ROA-18.69%Short Interest-Perf YTD8.05%
Book/sh2.72P/C-EPS next 5Y-ROE-56.87%52W High151.18 -25.19%Perf Year432.49%
Cash/sh4.46P/FCF-EPS past 3/5Y-ROIC-17.89%52W Low20.20 459.90%Perf 3Y-
Dividend Est.-EV/EBITDA-30.84Sales past 3/5Y-Gross Margin0.00%Volatility3.46% 4.06%Perf 5Y-
Dividend TTM-EV/Sales0.00EPS Y/Y TTM51.09%Oper. Margin0.00%ATR (14)6.95Perf 10Y-
Dividend Ex-Date-Quick Ratio28.88Sales Y/Y TTM-Profit Margin0.00%RSI (14)49.93Recom1.88
Dividend Gr. 3/5Y-Current Ratio28.88EPS Q/Q45.21%SMA201.27%Beta1.76Target Price225.00
Payout0.00%Debt/Eq0.00Sales Q/Q-SMA50-5.10%Rel Volume1.62Prev Close112.63
Employees14LT Debt/Eq0.27EarningsAug 13SMA20015.77%Avg Volume236.59KPrice113.10
IPO DateJan 02, 2015Option/ShortYes / YesEPS/Sales Surpr.-33.33% -Net Debt/EBITDA5.63Volume383,247Change0.42%
Analyst Ratings
DateActionAnalystRatingTarget
May-12-26InitiatedStephensOverweight$220
Feb-24-26ReiteratedTruist Financial$190 → $210
Feb-24-26ReiteratedStifel Nicolaus$180 → $250
Feb-24-26ReiteratedH.C. Wainwright$200 → $255
Feb-24-26ReiteratedChardan CapitalBuy$174 → $210
Jan-07-26InitiatedMizuhoOutperform$205
Dec-16-25ReiteratedRaymond JamesStrong Buy$143 → $193
Dec-16-25ReiteratedCanaccord GenuityBuy$90 → $204
Dec-15-25ReiteratedTruist Financial$105 → $190
Dec-15-25ReiteratedUBS$143
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
Total Revenue4300
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A300
Gross Profit4000
Selling, General and Administrative Excl. Other16166
Research and Development41238
Other Operating Expense000
Operating Income-16-39-14
Interest Expense064
Unusual Expense
———
Non-Operating Income (Expense)9-3-1
Net Income Before Taxes-25-42-17
Income Taxes
000
Consolidated Net Income-25-42-17
Net Income From Continuing Operations-25-42-17
Net Income-25-42-17
EPS (Recurring)-21.80-3.71-7.83
EPS (Basic, Before Extraordinaries)-21.80-3.71-7.83
EPS (Diluted)-21.79-3.71-7.83
EBITDA-23-36-13
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio
2.63——
Gross Margin93.02——
Operating Margin-37.21——
Net Margin-58.14——
Shares Outstanding1112
Market Capitalization1131,151—
Operating Lease Expense
———
Insider Trading Volume
$132.20$117.23$102.25$87.28$72.31● Close Price0.00K200.00K400.00K600.00K800.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Korenberg Matthew ECFO, TreasurerJun 12 '26Option Exercise13.602,00027,200166,100Jun 16 12:00 AM
Goin KathleenChief Operating OfficerMay 20 '26Option Exercise8.118,60469,76810,781May 22 12:00 AM
Goin KathleenChief Operating OfficerMay 20 '26Sale110.564,302475,6310May 22 12:00 AM
Goin KathleenChief Operating OfficerApr 15 '26Option Exercise8.118,60469,76812,935Apr 17 12:00 AM
Goin KathleenChief Operating OfficerApr 15 '26Sale127.244,302547,3990Apr 17 12:00 AM
JENKINS GEORGE MDirectorMar 30 '26Buy112.3044549,974187,616Apr 01 12:00 AM
Goin KathleenChief Operating OfficerMar 18 '26Option Exercise8.118,60469,76815,089Mar 20 12:00 AM
Goin KathleenChief Operating OfficerMar 18 '26Sale117.994,302507,6110Mar 20 12:00 AM
JENKINS GEORGE MDirectorFeb 27 '26Buy125.004,000500,000187,171Mar 02 12:00 AM
HERON ELAINE JDirectorFeb 27 '26Buy125.002,400300,00047,812Mar 02 12:00 AM
Goin KathleenChief Operating OfficerFeb 18 '26Option Exercise8.118,60469,76817,243Feb 20 12:00 AM
Goin KathleenChief Operating OfficerFeb 18 '26Sale79.404,302341,5640Feb 20 12:00 AM
Goin KathleenChief Operating OfficerJan 21 '26Option Exercise8.118,60469,76819,397Jan 23 12:00 AM
Goin KathleenChief Operating OfficerJan 21 '26Sale97.634,302419,9830Jan 23 12:00 AM
Goin KathleenChief Operating OfficerDec 17 '25Option Exercise8.118,60469,76821,551Dec 19 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR